Combination of Ceftazidime-Avibactam and Aztreonam Effectively Treated Post-Cardiac Surgery Pneumonia Caused by Hypervirulent KPC- and NDM-Producing Klebsiella pneumoniae: A Case Report
Abstract
Background: Hypervirulent carbapenem‑resistant Klebsiella pneumoniae (hv-CRKP) co‑producing Klebsiella pneumoniae carbapenemase‑2 (KPC‑2) and New Delhi metallo‑β‑lactamase‑1 (NDM‑1) represents a serious clinical threat due to limited treatment options and high mortality. This study aimed to describe the clinical course, microbiological characteristics, and therapeutic outcome of a severe postoperative pneumonia caused by such a strain, and to evaluate the effectiveness of combination antimicrobial therapy.
Case presentation: A 59‑year‑old woman developed severe pneumonia and acute respiratory distress syndrome following cardiac surgery. Bronchoalveolar lavage fluid culture yielded carbapenem‑resistant K. pneumoniae. Antimicrobial susceptibility testing showed resistance to meropenem (minimum inhibitory concentration [MIC] ≥16 μg/mL), ceftazidime‑avibactam (CZA) (MIC ≥16/4 μg/mL), and aztreonam (ATM) (MIC ≥64 μg/mL). Molecular analysis identified bla KPC and bla NDM carbapenemase genes and hypervirulence‑associated genes including rmpA and iucA. In vitro synergy testing demonstrated a marked reduction in MIC (≤1 μg/mL) when CZA was combined with ATM. Based on these findings, combination therapy was initiated, resulting in rapid clinical improvement, a decline in procalcitonin levels from 4.83 ng/mL to 0.5 ng/mL, radiographic resolution of pulmonary infiltrates, and sustained microbiological clearance.
Conclusion: This case demonstrates that CZA combined with ATM may be an…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.